Search
for

    Sort by

    Research 17

    1. Redefining hormone resistance in prostate cancer Therapeutic Advances in Medical Oncology · 2009 · 38 citations
    2. Recent discoveries and developments of androgen receptor based therapy for prostate cancer MedChemComm · 2015 · 17 citations
    3. Androgen Receptor in Human Health: A Potential Therapeutic Target Current Drug Targets · 2012 · 12 citations
    4. Human Derived Immortalized Dermal Papilla Cells With a Constant Expression of Testosterone Receptor Frontiers in Cell and Developmental Biology · 2020 · 8 citations
    5. Management of Advanced Prostate Cancer Undergoing Major Shift Oncology times · 2011
    6. The 5 Alpha-Reductase Isozyme Family: A Review of Basic Biology and Their Role in Human Diseases Advances in Urology · 2011 · 218 citations
    7. Combined Oral Contraception and Bicalutamide in Polycystic Ovary Syndrome and Severe Hirsutism: A Double-Blind Randomized Controlled Trial The Journal of Clinical Endocrinology & Metabolism · 2017 · 25 citations
    8. Androgen receptor modulators: a review of recent patents and reports (2012-2018) Expert Opinion on Therapeutic Patents · 2019 · 23 citations
    9. Androgen Receptor Mutations and Polymorphisms in African American Prostate Cancer International Journal of Biological Sciences · 2014 · 23 citations
    10. Targets to treat androgen excess in polycystic ovary syndrome Expert Opinion on Therapeutic Targets · 2015 · 14 citations
    11. Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases Current Medicinal Chemistry · 2016 · 11 citations
    12. Abiraterone and spironolactone in prostate cancer: a combination to avoid Acta Clinica Belgica · 2018 · 9 citations
    13. Sex hormones and related compounds, including hormonal contraceptives Side effects of drugs annual · 2014
    14. MARIO LACOUTURE: How Do I Treat a Patient with Dermatologic Toxicities to EGFR Inhibitors? Oncology times · 2011
    15. Design, synthesis and anti-tumor evaluation of novel thiohydantoin congeners as androgen receptor antagonists with in vivo study. Journal of molecular structure · 2024
    16. Aldo-Keto Reductase (AKR) 1C3 inhibitors: a patent review Expert opinion on therapeutic patents · 2017 · 70 citations
    17. Newly Developed Targeted Therapies Against the Androgen Receptor in Triple-Negative Breast Cancer: A Review Pharmacological Reviews · 2022 · 49 citations